The Impact of Second-Generation Antiandrogens on Drug Interactions in Prostate Cancer Therapy

This chapter examines the efficacy of second-generation antiandrogens in prostate cancer treatment, with a focus on their interactions with the cytochrome P450 enzyme system. It emphasizes the importance of understanding these interactions for patient management, particularly regarding the safety profile of darolutamide compared to enzalutamide and apalutamide.